All News

David O’Malley, MD, Discusses Findings From the OReO Trial in Ovarian Cancer at 2021 ESMO
September 23, 2021

CancerNetwork® sat down with David O’Malley, MD, at the 2021 European Society for Medical Oncology to talk about the OReO trial and how these findings impact what’s already known about PARP inhibitors for the treatment of ovarian cancer.

FDA Approves Additional Pfizer COVID-19 Vaccine Booster For Certain Populations
September 23, 2021

The FDA approved the use of the Pfizer COVID-19 vaccine for patients of a specific age, at risk jobs, or with serious health conditions.

Alrizomadlin Granted FDA Fast Track Designation for Relapsed/Refractory Unresectable or Metastatic Melanoma
September 23, 2021

Patients with relapsed/refractory unresectable or metastatic melanoma may derive benefit from alrizomadlin, which has received a fast track designation from the FDA.